Objective: Adjuvant protocols devised to enhance motor recovery in subacute stroke patients have failed to show benefits with respect to classic therapeutic interventions. Here, we evaluate the efficacy of a novel brain state-dependent intervention based on known mechanisms of memory and learning that is integrated as part of the weekly rehabilitation program in subacute stroke patients. Methods: Twenty-four hospitalized subacute stroke patients were randomly assigned to 2 intervention groups: (1) the associative group received 30 pairings of a peripheral electrical nerve stimulus (ES) such that the generated afferent volley arrived precisely during the most active phase of the motor cortex as patients attempted to perform a movement; and (2) in the control group, the ES intensity was too low to generate a stimulation of the nerve. Interpretation: This is the first evidence of a clinical effect of a neuromodulatory intervention in the subacute phase of stroke. This was evident with relatively few repetitions in comparison to available techniques, making it a clinically viable approach. The results indicate the potential of the proposed neuromodulation system in daily clinical routine for stroke rehabilitation. ANN NEUROL 2019;85:84-95 
I
n recent years, several adjuvant therapies based on noninvasive brain stimulation (NIBS; for review see Cirillo et al 1 ) have been devised for enhancing the spontaneous biological recovery process following stroke. 1, 2 The basic assumption is that NIBS "primes" the motor cortex for subsequent learning, which then occurs during a period of increased cortical excitability. However, the benefits of NIBS for function or motor learning are relatively small 3 and the responses are highly variable between and within patients. The source of this variability remains unclear, but may be related to the diffuse set of cortical neurons activated by NIBS, which exhibit either inhibitory or excitatory actions in the motor cortex. 4 The efficacy may thus be related to the overall state of excitability of the cortical network, referred to as the brain state. Applying NIBS during specific brain states may enhance its effectiveness. 5 We have recently demonstrated that a brain statedependent peripheral stimulation protocol induces significant plasticity of the damaged cortex in chronic stroke patients that translates directly into improved function. 6 Peripheral nerve stimulation is timed to arrive at the motor cortex during the peak negative (PN) phase of the movement-related cortical potential (MRCP), inducing a causal and systematic relation between the sensory signals arising from muscles involved in the movement and the physiologically generated brain wave during imagination or attempt of that movement (Fig 1) . This intervention exhibits many of the characteristics of associative long-term potentiation, one of the primary mechanisms for memory formation and learning, 7, 8 as its effects develop rapidly, are long lasting, depend on the timing of the 2 inputs, and are specific to the targeted muscle. [9] [10] [11] One of the advantages of triggering peripheral stimulation based on the physiological activation of the motor cortex is the active participation of the patients. 12 A very small number of pairings are sufficient to promote cortical plasticity when the delay is precisely timed. 6 This approach can be exploited in a brain-computer interface (BCI) technology that detects the brain activation patterns of patients and triggers peripheral stimulation. Preliminary studies of healthy participants have shown the feasibility of this approach. 10, 11 In the current study, we present for the first time the concept of brain state-dependent peripheral stimulation in subacute stroke patients. We hypothesized that the proposed intervention would lead to an increase in function of the affected limb that is directly measurable through clinical scales. Furthermore, we hypothesized an enhancement of the output of the motor cortex to the target muscle following a very short intervention time (ideally, even within a single session). The demonstration of this hypothesis would strongly support the theory that timing is critical and that associativity is the main physiological mechanism underlying the induced plasticity.
Patients and Methods

Ethical Approval
Patient demographic data and baseline clinical evaluations are shown in Table 1 . Eighteen male and 6 female patients (age = 61.2 AE 8.2 years) participated in this study. Inclusion criteria were age > 18 years, a superior division middle cerebral artery stroke within 4 months of inclusion in the study, and the ability to follow instructions. All patients underwent neuropsychological assessment, with none meeting the Diagnostic and Statistical Manual of Mental Disorders, 4th edition criteria for diagnosis of dementia. Patients were excluded if they presented with concomitant neurological or other severe medical problems, seizure history, contraindications to transcranial magnetic stimulation (TMS), cognitive impairments, treatment with drugs that act on the central nervous system, cardiovascular or respiratory symptoms contraindicative of walking, or any other significant non-stroke-related impairments affecting walking. All patients were recruited at the neurorehabilitation center at Neuroenhed Nord, North Jutland Regional Hospital, Brønderslev, Denmark, where they received intensive, multidisciplinary individualized rehabilitation therapy. Participation in this study was in addition to all therapies delivered at the hospital, and all hospital staff were blinded to the experimental protocol. Approval for the study was given by the Scientific Ethics Committee for Nordjylland, Denmark (reference no. N-20160016). The study was performed in accordance with the Declaration of Helsinki. Patients watched a screen placed 2m in front of them on which a cue provided information on when to attempt the dorsiflexion movement. FOCUS appeared on the screen initially followed by the schematic of a step function. Patients were required to start the attempted movement once the moving cursor (triangle) reached the upward slope. Finally, the word REST appeared last on the screen prior to the start of the next trial. Relevant brain activity was detected and measured, and the time of the peak negative (PN) phase of the movement-related cortical potential (MRCP) was extracted in the first 30 trials. In the subsequent 30 trials, this time was used to provide an output command for an electrical stimulator. The stimulator applied a single pulse (1-millisecond duration) to the deep branch of the common peroneal nerve (CPN). For the associative intervention group, the induced sensory signal produced by the electrical stimulation applied to the CPN was timed to arrive at the motor cortex during the time of maximum activation of the motor cortex as seen in the electroencephalographic (EEG) signal. The stimulation intensity was set to 1 × motor threshold. For the sham intervention group, the stimulation intensity was set below perception threshold such that there would be no resultant afferent volleys sent to the cortex. Thirty such pairs were performed. [Color figure can be viewed at www.annalsofneurology.org] Sample size calculations were based on pilot testing of the current protocol in 3 subacute stroke patients who improved 6 AE 3 points on the lower extremity FuglMeyer (LE-FM) motor performance assessment. Our control group was expected to improve by 1.5 AE 2 points. 13 A power analysis revealed that the minimum sample size necessary to achieve a statistical power of at least 95% (2-tailed α = 0.05) was n = 10 in each group. 24 The reference electrode was placed on the left or right earlobes and the ground electrode on Fz. A single channel surface electromyogram (EMG) was recorded from the tibialis anterior (TA) muscle of the affected leg to control for the patients' movement. All EEG and EMG signals were sampled at a frequency of 256Hz, and hardware was filtered from 0 to 100Hz. Patients were asked to attempt 30 dorsiflexion movements of the foot contralateral to the lesion site in relation to a visual cue. The experimental setup and cue are depicted in Figure 1 . A custom-made MATLAB script (R2014b; MathWorks, Natick, MA) provided this cue via a screen positioned 1.5m in front of the patient on when to mentally prepare, execute, and release the movement. Patients were instructed to attempt to perform a single dorsiflexion movement as fast as possible when the cursor had reached the upward turn and to maintain the new position for 2 seconds, following which they relaxed again for 4 to 5 seconds prior to the next cue being provided. Data from recorded EEG signals were used to quantify the time of PN of the MRCPs before proceeding to either the associative or sham interventions described under the section Interventions below.
Feature Extraction from the MRCP MATLAB software (R2014b, MathWorks) was used to filter the continuous EEG signals using a second order band-pass filter from 0.05 to 10Hz. EEG data were then divided into 4-second epochs (from 2 seconds before to 2 seconds after the visual cue) for each movement, and a Laplacian channel 24 was used to enhance the MRCP in each epoch. Next, a window of 500 milliseconds on either side of task onset was chosen. If any epoch's PN was outside the selected window, it was discarded. Epochs with electrooculographic activity exceeding 140 μV were also discarded. The remaining epochs were averaged, and the mean PN was defined as the time of occurrence of the minimum value of the averaged MRCP in relation to the visual cue. The mean PN was used to calculate the point in time for when to apply the peripheral stimulation in the subsequent intervention session for both patient groups.
Recording and Stimulation EMG activity was recorded by surface Ag/AgCl electrodes (20mm Neuroline 720; Ambu, Ballerup, Denmark) placed over the belly of the TA muscle of the affected leg. 25 Surface EMGs were preamplified and sampled at 2kHz using scientific software Mr. Kick II 2.3 (Knud Larsen, SMI, Aalborg University, Aalborg, Denmark) for recordings of the motor evoked potentials (MEPs) evoked by TMS in the TA during sessions 1, 6, and 12. During the intervention, EMG data were collected using the g. USBamp amplifier at a sampling frequency of 256Hz. A monophasic Magstim 200 (Magstim, Dyfed, UK) with a focal figure-of-eight double cone coil (110mm diameter) was used to apply single TMS pulses to elicit an MEP in the TA. The direction of the current was directed from posterior to anterior. MEPs were elicited before (pre), immediately after (post), and 30 minutes after (post30) the cessation of the intervention for both groups during intervention sessions 1, 6, and 12. For the procedure, see the section Quantification of corticospinal output.
Stimulation (pulse width = 1 milliseconds) of the common peroneal nerve (CPN) was applied by a NoxiTest isolated peripheral stimulator (IES 230; SMI, Aalborg, Denmark). Stimulating electrodes (32mm, PALS platinum patented conductive neurostimulation electrodes; Axelgaard Manufacturing, Fallbrook, CA) were placed on the skin overlying the deep branch of the CPN (L4 and L5) contralateral to the lesion site with the cathode proximal. A suitable position for stimulation, defined as the site where a maximal M wave was produced in the TA with no activity from the synergistic peroneal muscles and no activity from the antagonist soleus, was identified. The stimulation site corresponded to a point just anterior to the level of the caput fibulae. Initially, the motor threshold (MT) was determined as the intensity where an M wave became visible in the EMG signal. For the associative intervention group, the stimulation intensity was set to the MT. For the sham intervention group, the stimulation intensity was set to $70% of the perception threshold.
Quantification of Corticospinal Output
Patients were seated comfortably with their affected foot resting on a footplate. Initially, the intensity for the magnetic stimulus was set at approximately 50% of the stimulator output to find the optimal site for evoking an MEP in the TA. Three consecutive stimuli, at a 5-to 7-second interstimulus interval, were delivered over Cz, and this was repeated for different sites by moving the coil in $1cm steps anteriorly and laterally. The best spot for stimulation (also termed the hotspot) was defined as the coordinate where the peak-to-peak amplitudes of the MEPs were greater in the target muscle than the amplitudes of adjacent coordinates for a given stimulus intensity. For all patients, this site was approximately 2 to 3cm anterior to the vertex. Once the hotspot was identified, it was marked on the patients' head with a felt pen to ensure that the coil position was maintained and the stimuli were consistently delivered over the same area of the motor cortex.
Subsequently, the resting MT (RMT), defined as the highest stimulus intensity that produced no more than 5 of 10 consecutive TA MEPs with a peak-to-peak amplitude of $50 μV while the muscle was at rest, was identified. Next, 10 MEPs were elicited in the resting TA at each of 6 TMS intensities; 90, 100, 110, 120, 130, and 140% of RMT (60 MEPs in total). The TMS stimuli were delivered every 5 to 7 seconds in a randomized order of intensity. The mean peak-to-peak TA MEP amplitudes were extracted at pre, post, and post30.
Interventions
For the associative group, the intervention protocol consisted of a single electrical stimulation delivered to the CPN at MT and so that the artificially generated afferent flow arrived at the PN of the MRCP, as outlined in our previous publications. 6, 9 The timing was calculated based on the following equation: mean PN − 50 milliseconds. Fifty milliseconds represents the mean latency for the afferent inflow resulting from the peripheral stimulus to reach the somatosensory cortex plus a cortical processing delay and is based on previous work. 26 For the sham group, the electrical stimulus was delivered at the same time as for the associative group but at an intensity below MT ($70%) to ensure that no afferent inflow reached the cortex at the time of PN. A total of 30 pairings of attempted movement according to the cue (see Fig 1) and electrical stimulus were applied during each intervention session. Patients attended a total of 12 separate intervention sessions, with 3 sessions per week over 4 weeks. A minimum of 24 hours elapsed between sessions. Patients were blinded as to the intervention they received.
Statistical Analyses
The main outcome measures were the clinical tests and the changes in MEP amplitude. Any differences in preintervention clinical measures (mRS, LE-FM, ASS, and 10m walking test) between groups were evaluated with MannWhitney U tests. To test whether there was a change in clinical measures due to the interventions, separate Wilcoxon signed rank tests were employed for each group for the mRS, LE-FM, and ASS scores and the 10m walking test speed. To compare improvements in these clinical measures, Mann-Whitney U tests analyzed the absolute prepost intervention differences between the associative and sham groups. Ten-meter walking test speed was analyzed using nonparametric tests because of violations to the assumption of normality. Bonferroni adjustments were applied to correct for multiple comparisons. A 2-way between-within analysis of variance (ANOVA), with session (sessions 1, 6, 12) as the within-subject factor and group (associative, sham) as the between-subjects factor, was used to evaluate RMT and the premeasures of TA MEPs evoked at the highest stimulation intensity across testing sessions and groups. Greenhouse-Geisser-corrected degrees of freedom were used to correct for violations of the assumption of sphericity. Finally, changes in TA MEP were analyzed by a repeated measures mixed effects ANOVA. Subject was a random effects factor nested within group (associative, sham) with session (sessions 1, 6, 12), time (pre, post, and post30), and stimulation intensity (90%, 100%, 110%, 120%, 130%, 140% RMT) as within-subject fixed factors. Post hoc Fisher least significant difference corrections were administered to determine the locus of the differences. 27 Differences with a probability of <0.05 were considered significant. Statistical analyses were conducted in Minitab 18 (Minitab, State College, PA).
Results
Clinical Measures
Baseline clinical scores for both groups are shown in Table 2 . There were no statistically significant differences between the associative and sham groups for the LE-FM (95% confidence interval [CI] = −7 to 3), mRS (95% CI = −1 to 1), FAC (95% CI = −1 to 1), ASS (95% CI = 0-0), or 10m walking speed (95% CI = −0.65 to 0.58m/s; all p > 0.50) upon enrollment. At baseline, a total of 8 patients presented with no visible voluntary muscle activation of the TA and were unable to perform the dorsiflexion movement, 13 patients had limited dorsiflexion abilities as quantified by the LE-FM scale, and 3 patients were able to perform a complete dorsiflexion movement. Figure 2A shows the individual and median improvements in LE-FM scores following the associative or sham interventions. The absolute pre-post intervention period difference scores for both groups are shown in Figure 2B The associative and sham groups significantly improved in their mRS scores from 4 (IQR = 3-4) to 2.5 (IQR = 2-3.3) and from 4 (IQR = 2.8-4) to 3 (IQR = 2-3), respectively (both Z ≥ 2.13, both p ≤ 0.033), with no significant difference in improvements between groups (p = 0.93, 95% CI = −1 to 1). Additionally, both groups equally improved their FAC score from 2 (IQR = 1.8-4) to 4 (IQR = 3.8-5) and from 2 (IQR = 1.8-4) and 4 (IQR = 4-5), respectively (both Z = 2.71, both p = 0.007), with no difference in improvement (p > 0.99, 95% CI = −1 to 1). For the ASS, no significant changes were detected for either the associative or sham groups (both p > 0.30, 95% CI = 0-0).
Two patients from each of the associative and sham groups could not walk either at baseline or after the 4-week intervention period. There were 5 patients in the associative group and 3 patients in the sham group who could not walk at baseline but could walk after the 4-week intervention period. In these instances, patients were assigned a walking speed of 0m/s and included in the statistical analyses. The associative and sham groups significantly improved their walking speed in the 10m walking test from 0.59 AE 0.77 to 1.09 AE 0.78m/s and from 0.63 AE 0.67 to 0.95 AE 0.75m/s, respectively (both Z ≥ 2.67, both p ≤ 0.008), with no difference in improvement between groups (p = 0.56; 95% CI = −0.21 to 0.56m/s).
Reliability of the MRCP
The associative intervention as applied in the current study requires the MRCP to be stable within a session, because the arrival of the afferent inflow to the motor cortex has to occur at the precise time of the PN phase of the MRCP. However, as each session commenced with the identification of the occurrence of the time of PN of the MRCP, variability across days is expected and may even be a further marker for plasticity induction. The 2 upper panels of Figure 3 show the time of occurrence of the PN of the MRCP for each session for 2 patients. Also shown are the standard deviations. The lower panel displays the average PN time across all sessions for each patient in the associative group. Across all patients, the time of PN of the MRCP occurred at −60 AE 55 milliseconds prior to the cue to commence the movement.
Changes in Corticospinal Output Properties
Because of patients' compliance with TMS, it was not always possible to elicit MEPs. For session 1, 11 of 12 patients were included in the analyses from each group. For session 6, 7 of 12 associative group patients and 8 of 12 sham group patients were included in the analyses, and for session 12, 11 of 12 associative group patients and 10 of 12 sham group patients were included. The RMT did not change before or after the training for either group. For the associative group, the mean (AEstandard deviation) RMT was 56.8 AE 16.6%, 59.0 AE 13.3%, and 53.9 AE 9.5% maximum stimulator output (MSO) in sessions 1, 6, and 12, respectively. For the sham group, the mean RMT was 49.2 AE 12.3%, 48.1 AE 11.2%, and 53.3 AE 13.3% MSO in sessions 1, 6, and 12, respectively. A 2-way between-within participants ANOVA revealed no significant interaction between group and session (p = 0.14), nor main effect of session (p = 0.95) or group (p = 0.23). In Patient A05, the RMTs were 84 and 73% MSO for session 1 and 6, respectively, and for Patient A07 it was 79% MSO for session 1. Thus, it was not possible to obtain a complete recruitment curve up to 140% RMT on these occasions.
The amplitude of the TA MEPs evoked at the highest stimulation intensity before the commencement of the intervention sessions across all patients attained values of 323 AE 182 μV, 303 AE 220 μV, and 425 AE 224 μV for the associative group and 471 AE 299 μV, 382 AE 306 μV, and 454 AE 500 μV for the sham group for sessions 1, 6, and 12, respectively. There was no significant session by group interaction, nor any main significant effects of session or group (all p > 0.52), indicating that the maximal preintervention session MEPs did not change systematically throughout the intervention period. Figure 4 shows the mean TA MEP amplitude for the patients in the associative and sham group, plotted against TMS intensity for intervention sessions 1, 6, and 12. Data are expressed as a fraction of the maximum TA MEP amplitude prior to the intervention of the respective session. The linear mixed model analysis on TA MEP amplitudes revealed no significant 4-or 3-way interactions between session, time, stimulation intensity, or group (all p > 0.80). However, there was a significant 2-way interaction between time by group, F 2, 964 = 3.72, p = 0.024. 
Discussion
This is the first systematic study on subacute stroke patients that explicitly explores the associative long-term potentiation theory within a brain state-dependent rehabilitation approach. Patients enrolled in the associative intervention improved motor function significantly more compared with the sham group. The implication is that the intervention presented here has the potential to boost recovery beyond the spontaneous biological recovery processes in the first few months after the insult. Furthermore, it opens the possibility to develop an online BCI system for patients where the intention to move is detected from continuous monitoring of the brain signals and used to trigger the peripheral stimulation that generates the afferent feedback to the brain at the precise time of the PN phase of the MRCP. This online BCI has been tested in healthy participants, where it led to significant increases in the excitability of the cortical projections to the target muscle. 10, 11 In the current study, we specifically tested the scientific hypothesis of associative plasticity without the BCI component to eliminate confounding factors (such as the possibility that different patient groups have different detection accuracy). Nonetheless, the current results have direct implications for a future BCI system that allows stroke patients to control their own recovery process.
To date, clinical studies on the use of BCI for stroke therapy have involved chronic patients. Although this choice simplifies the study design because of the stable conditions of the patients, a real impact in stroke therapy can only be achieved in the acute and subacute phase of the stroke. This is the time window critical for recovery, as the greatest gains are achieved in this interval. 28 During this time, genes and proteins for synaptogenesis, neuronal growth, and dendritic sprouting are expressed to a greater extent following a stroke. 29 It is in this state that the brain is highly plastic, and it is likely that the same synaptic rules for learning and memory formation will lead to the most optimal outcome. 28 Addressing patients in this time window is extremely challenging for neurotechnology developments because of the variability of symptom distribution and symptom severity 28 as well as limited patient compliance and variability in brain electrical activity. These conditions impose strong constraints in the development of the technology as proposed here, as it relies on the accurate and early detection of movement intention from EEG signals. Whereas chronic stroke patients exhibit rather stable MRCPs between days, 6 this is not the case for subacute stroke patients (see Fig 3) . This necessitates the collection of a training dataset prior to the associative intervention, where patients attempt the motor task in a number of repetitions. However, in the proposed intervention, each session only requires a maximum of 20 to 25 minutes, which includes the preparation time. This is well within the timeframe typically used for other therapeutic procedures. In this way, our approach is easily transferred into the clinical setting. Neural repair following stroke specifically involves adjacent sites around the lesion as well as remote sites that are connected to the damaged area. 30 Generally, the increased activity in remote sites as well as increased activity in the contralesional hemisphere during motor execution declines with recovery and the degree of this decline is correlated with the amount of function regained. 31 Within the time window of spontaneous biological recovery, significant axonal sprouting occurs that has the potential to be the target for novel therapies, although not all sprouting processes are beneficial. 32 The intent of the associative intervention as presented here is thus to guide plasticity by directly activating specific pathways known to be dysfunctional following a stroke. By repetitively pairing the intent of the patient, as quantified by the MRCP, with the artificially generated afferent inflow to the ipsilesional motor cortex, the associative intervention directly follows the principles of memory formation and learning first proposed by Hebb. 33 This targeted plasticity induction significantly improved functionality, and may thus promote beneficial plasticity processes such as axonal sprouting between those cortical areas that should be connected and between peripheral sensory receptors and cortical areas. 28 Sensory information from muscle receptors plays an integral part in motor learning. 34 That the patients exposed to the associative intervention improved significantly more than the sham group supports the importance of the correct pairing in time of the peripherally generated signal and the MRCP. It should be noted that there were no significant improvements in the secondary functional outcome scores (ie, the ASS or mRS). This is in agreement with previous reports. 6, 13, 35 The reasons for the lack of improvements in these functional outcome scores remain speculative, but at least in the current study it can be partly explained by only 2 patients presenting with spasticity at enrollment. The rationale of the proposed intervention is similar to that underlying paired associative stimulation (PAS; for review see Suppa et al. 36 PAS uses a peripherally generated afferent volley, as in our approach, and combines it with a second stimulation to the area of the motor cortex representing the target muscle with TMS. The interstimulus interval is such that the afferent volley arrives just prior to the TMS stimulus. However, PAS is not as effective as our intervention, as approximately 50% of participants do not exhibit the expected change in excitability following PAS. 36 The lower efficacy of PAS may be due to a diffuse activation by TMS of a set of both inhibitory and excitatory cortical neurons. In agreement with this interpretation, NIBS protocols that use either TMS or direct transcranial current stimulation have shown large variability in their effects between individuals as well as within individuals across days. 1 In our approach, the activation of the cortical areas occurs naturally through the patient's own attempt at performing the movement and thus the relevant brain areas are activated in a more natural manner. However, what remains to be investigated is the exact site of plasticity induction. Thus, in the current study, the significant functional improvements, as quantified by the LE-FM scale and the 10m walk test, were accompanied by significant increases in MEP size only in the associative group. This is an indication of plastic changes within the corticospinal tract 37, 38 ; in future studies it will be important to identify the exact locus of these changes and thus the associated functional changes using techniques such as resting functional magnetic resonance imaging or diffusion-weighted images. 38 The MRCP and the time of the PN of the MRCP varied from one session to the next for individual patients.
Although this variability was reduced for single trials within a single intervention session, values still ranged between 150 and 300 milliseconds. In the conventional PAS protocol, a difference of only 5 milliseconds between the timing of the 2 stimuli could induce an inhibitory rather than a facilitatory effect. 39 Thus, although our associative intervention is modeled on PAS, it is unlikely that the 2 interventions have the same sites for plasticity induction. Irrespective of the exact site, one factor that is likely to contribute to the enhanced effect of our protocol as compared to PAS is that it is a behavioral training, where the patient is actively involved in the intervention. The patient engagement, combined with the correlated activation of the relevant brain areas through the peripherally generated volley and the MRCP, leads to beneficial effects that are not seen in the sham intervention. Because the patients investigated here were hospitalized, one important goal during the development of the associative intervention was that it had to be complementary to the other activities the patients had to perform as part of the standard rehabilitation procedures in Denmark. Typically, patients at this stage have difficulty concentrating for long periods of time and experience more fatigue as compared to chronic stroke patients. The associative intervention introduced here requires only 30 movements to be performed in the initial phase where the PN of the MRCP is established and 30 in the actual intervention phase. The total duration of a single session, which includes preparation of the EEG and stimulation electrodes, is 20 minutes. It thus paves the way for this novel technology to be used within daily clinical practice.
